Literature DB >> 1587428

Histopathology of membranous obstruction of the inferior vena cava in the Budd-Chiari syndrome.

M Kage1, M Arakawa, M Kojiro, K Okuda.   

Abstract

It is generally believed that membranous obstruction of the inferior vena cava in the Budd-Chiari syndrome is caused by congenital malformation. However, it does not explain the late onset of the disease. In the current study, hepatic portion of the inferior vena cava and hepatic veins were studied in 17 autopsy cases of the Budd-Chiari syndrome, 16 of which had no demonstrable cause (idiopathic). A sufficient amount of vena cava tissue was available for evaluation in 15 cases. Nine had membranous obstruction, with thickness varying from 3 to 8 mm. Thrombus formation was recognized in 7 of 9 cases. Occlusion of hepatic vein orifices of varying degree was present in 8 cases. In these occluding lesions, the basic structure of the venous wall was maintained. The intima was transformed into a fibrous laminar structure, and organized thrombi of varying ages were recognized; they were a mixture of fresh thrombi, organized thrombi, fibrous tissues, recanalizations, and calcifications. It is concluded that in these cases of the Budd-Chiari syndrome, occluding and stenosing lesions in the inferior vena cava and hepatic veins were thrombosis and its sequelae. There was no indication of congenital malformation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587428     DOI: 10.1016/0016-5085(92)90336-w

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  20 in total

Review 1.  Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava).

Authors:  Santosh Man Shrestha
Journal:  World J Hepatol       Date:  2015-04-28

2.  Treatment of Budd-Chiari syndrome by metallic stent as a bridge to liver transplantation.

Authors:  L Martin; R F Dondelinger; G Trotteur
Journal:  Cardiovasc Intervent Radiol       Date:  1995 May-Jun       Impact factor: 2.740

Review 3.  Research status of Budd-Chiari syndrome in China.

Authors:  Xiaowei Dang; Luhao Li; Peiqin Xu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  A Rare Presentation of an Entrapment in a Liver Transplant Candidate Depicted by MDCT Angiography.

Authors:  Mecit Kantarci; Unal Aydin; Selim Doganay; Bulent Aydinli; Ihsan Yuce; Kamil Yalcin Polat
Journal:  Eurasian J Med       Date:  2010-08

5.  Endovascular stenting of IVC using Brockenborough's needle in Budd-Chiari syndrome--a case report.

Authors:  Pawan Poddar; Sudarsana Gurizala; Sudarshan Rao
Journal:  Indian Heart J       Date:  2014-04-16

6.  Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava.

Authors:  Santosh Man Shrestha
Journal:  Hepatol Int       Date:  2009-01-23       Impact factor: 6.047

7.  Budd-Chiari syndrome: hepatic venous web outflow obstruction treated by percutaneous placement of hepatic vein stent.

Authors:  Alireza Bozorgmanesh; D Arul Selvam; James G Caridi
Journal:  Semin Intervent Radiol       Date:  2007-03       Impact factor: 1.513

8.  The budd-Chiari syndrome in a child: a case report and review of the literature.

Authors:  Vatsala Misra; Kachnar Verma; Dharmendra Kumar Singh; Sri Prakash Misra
Journal:  J Clin Diagn Res       Date:  2012-12-15

Review 9.  Hepatic venous outflow obstruction: three similar syndromes.

Authors:  Ulas-Darda Bayraktar; Soley Seren; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

10.  Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Akash Shukla; Ananta Shreshtha; Amar Mukund; Chhagan Bihari; C E Eapen; Guohong Han; Hemant Deshmukh; Ian Homer Y Cua; Cosmas Rinaldi Adithya Lesmana; Mamun Al Meshtab; Masayoshi Kage; Roongruedee Chaiteeraki; Sombat Treeprasertsuk; Suprabhat Giri; Sundeep Punamiya; Valerie Paradis; Xingshun Qi; Yasuhiko Sugawara; Zaigham Abbas; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-07-08       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.